Canada's drug pricing plan prompts backlash
26-10-2020
Trump confounds big pharma with low-cost drugs import plan
01-08-2019
Canadian generics plan could deter big pharma: report
17-04-2019
Scotyard / Shutterstock.com
Innovative Medicines Canada (IMC), an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Innovative Medicines Canada, IMC, drug pricing, Canadian government, Health Canada, generics, Patented Medicine Prices Review Board
